Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?
Academic Article
Overview
MeSH Major
Opioid-Related Disorders
Prescription Drug Misuse
abstract
XR-NTX appeared to work equally well across subgroups with diverse demographic, addiction, mental health and environmental characteristics, with the possible exception of working better among those without recent alcohol intoxication. These findings should be reassuring to practitioners increasingly using XR-NTX as medical addiction therapy in diverse and often vulnerable populations.
